Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
TFF PHARMACEUTIC last posted its earnings results on Wednesday, November 20th, 2024. The company reported $-0.81 earnings per share for the quarter, missing analysts' consensus estimates of $-0.81 by $0. The company had revenue of 193.39 K for the quarter and had revenue of 733.87 K for the year. TFF PHARMACEUTIC has generated $-12 earnings per share over the last year ($-11.85 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. TFF PHARMACEUTIC has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/20/2024 | Q3 2024 | -$0.81 | -$0.81 | 0 | $150.00 K | $193.39 K |
| 08/14/2024 | Q2 2024 | -$1.70 | -$1.22 | 0.48 | $150.00 K | $650.22 K |
| 05/14/2024 | Q1 2024 | -$2.20 | -$2.40 | -0.2 | N/A | $203.27 K |
| 03/28/2024 | Q4 2023 | -$2.00 | -$2.01 | -0.01 | N/A | $733.87 K |
| 11/14/2023 | Q3 2023 | -$2.75 | -$2.32 | 0.43 | $50.00 K | $0 |
| 08/14/2023 | Q2 2023 | N/A | -$3.47 | N/A | $66.67 K | $333.35 K |
| 05/11/2023 | Q1 2023 | -$5.00 | -$4.76 | 0.24 | $250.00 K | $51.43 K |
| 03/31/2023 | Q4 2022 | N/A | -$5.10 | N/A | $33 | $0 |
| 11/14/2022 | Q3 2022 | -$7.75 | -$0.29 | 7.46 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$8.00 | -$0.34 | 7.66 | N/A | $0 |
| 05/11/2022 | Q1 2022 | -$9.50 | -$0.33 | 9.17 | $50.00 K | $0 |
| 03/24/2022 | Q4 2021 | -$7.50 | -$0.40 | 7.1 | $938.50 K | $0 |
| 11/15/2021 | Q3 2021 | -$3.50 | -$0.34 | 3.16 | $1.70 M | $0 |
| 08/12/2021 | Q2 2021 | -$7.00 | -$0.18 | 6.82 | N/A | $0 |
| 05/13/2021 | Q1 2021 | -$6.00 | -$0.33 | 5.67 | N/A | $0 |
| 03/10/2021 | Q4 2020 | -$5.75 | -$0.26 | 5.49 | $333.33 K | $0 |
| 11/05/2020 | Q3 2020 | -$5.00 | -$0.24 | 4.76 | $500.00 K | $0 |
| 08/13/2020 | Q2 2020 | -$5.25 | -$0.20 | 5.05 | N/A | $0 |
| 05/14/2020 | Q1 2020 | -$6.00 | -$0.20 | 5.8 | N/A | $0 |
| 03/26/2020 | Q4 2019 | N/A | -$0.33 | N/A | N/A | $0 |
The conference call for TFF PHARMACEUTIC's latest earnings report can be listened to online.
The conference call transcript for TFF PHARMACEUTIC's latest earnings report can be read online.
TFF PHARMACEUTIC (:TFFP) has a recorded annual revenue of $733.87 K.
TFF PHARMACEUTIC (:TFFP) has a recorded net income of $-21,243,231.TFF PHARMACEUTIC has generated $-11.85 earnings per share over the last four quarters.
TFF PHARMACEUTIC (:TFFP) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED